SKI Market

Indian Indices

Nifty

25,585.30 261.75
(1.03%)

Sensex

84,021.37 553.71
( 0.66%)

Bank Nifty

57,422.55 622.65
( 1.10%)

Nifty IT

35,531.05 129.25
( 0.37%)

Global Indices

Nasdaq

45,973.33 -300.99
(-0.65%)

Dow Jones

6,650.42 -41.64
(-0.62%)

Hang Seng

48,217.22 544.55
(1.14%)

Nikkei 225

9,436.09 11.34
(0.12%)

Forex

USD-INR

88.15 -0.61
(-0.69%)

EUR-INR

102.52 -0.28
(-0.27%)

GBP-INR

117.81 -0.31
(-0.26%)

JPY-INR

0.58 0.00
(-0.23%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Ajanta Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

532331

INE031B01049

290.1676063

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AJANTPHARM

33.03

30911.57

EPS(TTM)

Face Value()

Div & Yield %

74.9

1.14

Back

ajanta pharma ltd

Ajanta Pharma consolidated net profit rises 10.84% in the September 2024 quarter

Oct 28,2024

Net profit of Ajanta Pharma rose 10.84% to Rs 216.48 crore in the quarter ended September 2024 as against Rs 195.30 crore during the previous quarter ended September 2023. Sales rose 15.38% to Rs 1186.64 crore in the quarter ended September 2024 as against Rs 1028.44 crore during the previous quarter ended September 2023.

Particulars	Quarter Ended
	Sep. 2024	Sep. 2023	% Var.
Sales	1186.64	1028.44	15
OPM %	26.22	28.26	-
PBDT	324.63	309.65	5
PBT	290.24	275.94	5
NP	216.48	195.30	11

25,585.30 261.75 (1.03%)

84,021.37 553.71 ( 0.66%)

57,422.55 622.65 ( 1.10%)

35,531.05 129.25 ( 0.37%)

45,973.33 -300.99 (-0.65%)

6,650.42 -41.64 (-0.62%)

48,217.22 544.55 (1.14%)

9,436.09 11.34 (0.12%)

88.15 -0.61 (-0.69%)

102.52 -0.28 (-0.27%)

117.81 -0.31 (-0.26%)

0.58 0.00 (-0.23%)